Czarnogorski, Maggie
34  results:
Search for persons X
?
1

Safety and Effectiveness From the Cabotegravir and Rilpivir..:

Jonsson-Oldenbüttel, Celia ; Ghosn, Jade ; van der Valk, Marc...
JAIDS Journal of Acquired Immune Deficiency Syndromes.  96 (2024)  5 - p. 472-480 , 2024
 
?
3

1559. Healthcare Staff Perceptions of Feasibility and Accep..:

Torres, Julian A ; Dandachi, Dima ; Holder, Hadrian...
Open Forum Infectious Diseases.  10 (2023)  Supplement_2 - p. , 2023
 
?
4

1547. Integrating Long-acting Injectable Cabotegravir for P..:

Valenti, William M ; Phoenix, John ; Patel, Rupa R...
Open Forum Infectious Diseases.  10 (2023)  Supplement_2 - p. , 2023
 
?
5

Brief Report: Impact of COVID-19 on Cabotegravir Plus Rilpi..:

Czarnogorski, Maggie ; Benn, Paul ; McCoig, Cindy...
JAIDS Journal of Acquired Immune Deficiency Syndromes.  91 (2022)  2 - p. 157-161 , 2022
 
?
8

1584. CARISEL A Hybrid III Implementation Effectiveness Stu..:

De Wit, Stephane ; Rami, Agathe ; Bonnet, Fabrice...
Open Forum Infectious Diseases.  9 (2022)  Supplement_2 - p. , 2022
 
?
12

883. Qualitative Patient-Participant Perspectives on Implem..:

Garris, Cindy ; Stassek, Larissa ; D'Amico, Ronald...
Open Forum Infectious Diseases.  8 (2021)  Supplement_1 - p. S533-S533 , 2021
 
?
13

1037. Qualitative Findings from a Hybrid III Implementation..:

Czarnogorski, Maggie ; Garris, Cindy ; Wannamaker, Paul...
Open Forum Infectious Diseases.  7 (2020)  Supplement_1 - p. S549-S549 , 2020
 
?
14

1034. Patient Perspectives on Implementation of a Long-Acti..:

Garris, Cindy ; D'Amico, Ronald ; Wannamaker, Paul...
Open Forum Infectious Diseases.  7 (2020)  Supplement_1 - p. S547-S548 , 2020
 
1-15